|
|
Title:
Method of blunting the postprandial glycemic response to a meal
United States Patent: 8,029,818
Issued: October 4, 2011
Inventors: Wolf; Bryan W.
(Johnstown, OH)
Assignee: Abbott
Laboratories (Abbott Park, IL)
Appl. No.: 10/157,644
Filed: May 29, 2002
|
|
|
Outsourcing Guide
|
Abstract
The present invention relates to a method
for reducing the postprandial glycemic excursion to carbohydrates by
feeding supplemental fructose prior to the carbohydrate challenge. The
unit does of fructose required to blunt the postprandial glycemic
excursion is from about 2 grams to about 30 grams fructose. The fructose
source is consumed from about 10 to about 90 minutes before a meal.
Description of the
Invention
TECHNICAL FIELD
The present invention relates to a method for reducing the postprandial
glycemic excursion by feeding supplemental fructose prior to the
carbohydrate challenge and to its use in the dietary management of
diabetics.
INTRODUCTION
The control of blood glucose in people with diabetes mellitus is of
paramount importance for the long-term management of this disease. While
intensive treatment with insulin or oral glucose-lowering agents is of
great benefit, they are associated with an increased risk of hypoglycemia
and weight gain. The concomitant use of diet as adjunctive therapy for the
management of blood glucose further enhances the quality of life and
reduces the risk of hypoglycemia and weight gain in people with diabetes.
Furthermore, nutritional management should be the first mode of treatment
for people with insulin resistance or early stage type 2 diabetes mellitus
as well as a preventative therapy for high-risk populations (e.g., obese
and first degree relatives of people with type 2 diabetes mellitus).
American Diabetes Association (ADA) guidelines emphasize individualization
of diet strategies. The purpose is to achieve optimal glycemic and
metabolic control by varying the proportion of calories provided by the
macronutrients. The proportion selected depends on goals for glycemic
control, dietary preferences and response to the diet.
The ADA currently recommends a diet in which protein is the same as that
for the general population and accounts for 10% to 20% of total calories.
With protein contributing 10% to 20% of the total calories, 80% to 90% of
the total calories remain to be distributed between carbohydrate and fat.
The carbohydrate/fat mix is individualized according to dietary
preference, treatment goals, metabolic control and the presence of other
medical conditions. However, the ADA does make a recommendation for the
various types of fat in the diet. Specifically, saturated fat should
contribute less than 10% of total calories, and polyunsaturated fat
contributing no more than 10% of total calories. The remainder of fat
calories should come from monounsaturated fat and the daily intake of
cholesterol should be limited to less than 300 mg. The recommendation for
fiber intake is the same as for the general public with approximately 20
to 35 g/day of dietary fiber from a variety of food sources. The micro
nutrient requirements of otherwise healthy persons with diabetes mellitus
will likely be met by consuming the amounts suggested by the Reference
Daily Intakes (RDIs). Individuals considered at risk for micronutrient
deficiencies should be evaluated to determine if supplementation is
necessary. Because fructose and sucrose intake have been shown to cause
hypertriacylglycerolemia and hypercholesterolemia in rats and humans,
nutritional recommendations have been made to avoid supplementation of
simple sugars to the diabetic diet.
Products designed as nutritionals for the person with diabetes are
commercially available and typically include fructose as a sweetener.
These nutritional products are typically liquids or in a solid form such
as nutritional bars and baked goods.
Glucerna.RTM. (Ross Products Division of Abbott Laboratories, Columbus
Ohio) is a liquid nutritional with fiber for patients with abnormal
glucose tolerance. Sodium and calcium caseinates make up 16.7% of total
calories as protein; maltodextrin, soy polysaccharide and fructose make up
34.3% of total calories as carbohydrate; and high oleic safflower oil and
canola oil make up 49% of total calories as fat. Soy polysaccharide
contributes 14.1 g/1000 ml of total dietary fiber. The RDI for vitamins
and minerals is delivered in 1422 kcals. The product also contains the
ultra trace minerals selenium, chromium and molybdenum and the
conditionally essential nutrients carnitine and taurine.
Resource.RTM. Diabetic (Sandoz Nutrition Corporation, Berne, Switzerland)
is a complete liquid formula with fiber specifically designed for persons
with type 1 and type 2 diabetes and for persons with stress-induced
hyperglycemia. Sodium and calcium caseinates, and soy protein isolate make
up 24% of total calories as protein; hydrolyzed corn starch and fructose
make up 36% of total calories as carbohydrate; and high oleic sunflower
oil and soybean oil make up 40% of total calories as fat. Partially
hydrolyzed guar gum contributes 3.0 g/8 fl. oz. of total dietary fiber.
The RDI for vitamins and minerals is delivered in 2000 kcals. The product
also contains the ultra trace minerals selenium, chromium and molybdenum
and the conditionally essential nutrients carnitine and taurine.
Ensure.RTM. Glucerna.RTM. Shake (Ross Products Division of Abbott
Laboratories, Columbus Ohio) is an oral supplement specifically designed
for people with diabetes. Sodium and calcium caseinates and soy protein
isolate make up 18% of total calories as protein; maltodextrin, fructose,
maltitol, soy polysaccharide and FOS make up 47% of total calories as
carbohydrate; and high oleic safflower oil and canola oil make up 35% of
total calories as fat. Soy polysaccharide and fructooligosaccharides (FOS)
contribute 3.0 g/8 fl. oz. of total dietary fiber. At least 25% of the DV
for 24 key vitamins and minerals are delivered in 8 fl. oz. The product
also contains the ultra trace minerals selenium, chromium and molybdenum.
Ensure.RTM.Glucerna.RTM. Snack Bars (Ross Products Division of Abbott
Laboratories, Columbus Ohio) are complete, balanced nutritional bars
designed specifically for people with diabetes. Soy protein, rice protein,
corn protein and milk and cocoa (from the coating) make up 17% of total
calories as protein; high fructose corn syrup, honey, microencapsulated
guar gum, rice starch, maltodextrin, soy polysaccharide, glycerin,
microcrystalline cellulose, fructooligosaccharides (FOS) and maltitol
(from the coating) make up 57% of total calories as carbohydrate; and
partially hydrogenated soy and cottonseed oils, high oleic safflower oil
and canola oil make up 26% of total calories as fat. Microencapsulated
guar gum, soy polysaccharide, microcrystalline cellulose, FOS and
resistance starch contribute 4 g total dietary fiber per 1.34 oz bar. One
bar provides at least 15% of the DV for 24 key vitamins and minerals. The
product also contains the ultra trace minerals selenium, chromium and
molybdenum and the conditionally essential nutrient m-inositol.
Choice Dm.RTM. Bar (Mead Johnson & Company, Evansville, Ind.) is a
nutritional bar with fiber, antioxidants and 24 essential vitamins and
minerals for people with diabetes. Calcium caseinate, soy protein isolate,
whey protein concentrate, toasted soybeans, soy nuggets (soy protein
isolate, rice flour, malt, salt) and peanut butter make up 17.1% of total
calories as protein; lactose, fructose, sugar, dextrose, honey,
maltodextrin, rice syrup, sorbitol and peanut flour make up 54.3% of total
calories as carbohydrate; and palm kernel oil and canola oil make up 28.9%
of total calories as fat.
Typically, the commercial nutritionals are designed as meal replacements
and include all the macro and micronutrients required of a meal
replacement. These nutritionals typically utilize multiple sources of
carbohydrate that are absorbed at different rates to control the glycemic
response to the nutritional. While the nutritionals are handy for a busy
schedule when it is not practical to prepare a meal, many diabetics prefer
to eat "normal" food and do not want to routinely consume their entire
meal out of a can. There is clearly a need for an easy method to blunt the
glycemic response of a meal composed of "normal" food.
SUMMARY OF THE INVENTION
The nutritive sweetener, fructose, in itself is a dietary carbohydrate
source with a low postprandial glycemic excursion. Because of its reduced
glycemic response, fructose is an ideal carbohydrate for use in the
dietary control of postprandial glycemia in people with diabetes mellitus.
However, because fructose intake levels greater than 17% of total Kcal
have been shown to cause hypertriacylglycerolemia and hypercholesterolemia
in rats and humans, dietary recommendations for the diabetic have been
made to avoid high intakes of simple carbohydrates, especially fructose.
The inventors discovered that low amounts of supplemental fructose when
given along with a meal glucose tolerance test had no effect on the
postprandial glycemic response. However, when a low dose of fructose was
given prior to the meal tolerance test, fructose reduced the postprandial
glycemic response.
The present invention relates to a method for reducing the postprandial
glycemic excursion to carbohydrates by feeding supplemental fructose prior
to the carbohydrate challenge. The unit does of fructose required to blunt
the postprandial glycemic excursion is from about 2 grams to about 30
grams fructose, preferably from about 5 to about 15 grams of fructose,
more preferably about 10 grams of fructose. The fructose source is
consumed from about 10 to about 90 minutes before a meal, preferably from
about 15 to about 75 minutes before a meal, more preferably from about 30
to about 60 minutes before a meal.
The source of fructose may be any food grade fructose source such as
sucrose, maltitol, high fructose corn syrup, honey, fruit, fruit juice,
liquid fructose, powder fructose and crystalline fructose.
The fructose dose may be in any suitable form such as a tablet, caplet,
lozenge, powder, crystal, fruit, syrup, candy and liquid.
The method may be used for nutritional management of persons with
diabetes, for people with insulin resistance as well as a preventative
therapy for high-risk populations (e.g., obese and first degree relatives
of people with type 2 diabetes mellitus).
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a method of feeding fructose to a person
prior to a carbohydrate challenge, which significantly reduces the
postprandial glycemic excursion to that challenge. As described in Example
I, the inventors surprising discovered that 10 g supplemental fructose
when given with a meal glucose tolerance test (50 g carbohydrate from
instant mashed potatoes) had no effect on the postprandial glycemic
response. However, when 10 g of fructose were given 30 or 60 minutes
before the meal tolerance test, fructose reduced the postprandial glycemic
response.
The amount of fructose required to blunt the postprandial glycemic
excursion is from about 2 grams to about 30 grams, preferably from about 5
to about 15 grams of fructose, more preferably about 10 grams of fructose.
Any fructose source suitable for human consumption may be utilized in the
instant invention. Examples of typical fructose sources include sucrose,
maltitol, high fructose corn syrup, honey, fruit, fruit juice, liquid
fructose, powder fructose and crystalline fructose. Examples of suitable
fruit and fruit juices include apple, grape, orange, grapefruit, pear and
watermelon.
Fructose is found in fruits and honey. More typically, commercially
available fructose is produced by well known enzymatic conversion of
saccharides to fructose. The fructose content of various sources is listed
in Table 1 (see Original Patent).
Commercial high fructose corn syrup is available with various levels of
fructose. The high fructose corn syrup profiles listed in Table 1
represent typical commercially available high fructose corn syrup, with
fructose levels at 42% and 55% of the corn syrup, respectively. Typical
values for fructose sources of different fruit may be found in Human
Nutrition Information Service (1987) Sugar content of selected foods:
Individual and total sugars. (Home Economics Research Report no. 48, USDA,
Washington, D.C.) Examples of appropriate fruits include a raw apple (31/4
inch diameter) which typically contains 10.5 gm fructose and 4.6 gm of
sucrose; a Bartlett pear (21/2 inch diameter) typically contains 10.6 mg
fructose and 3 gm of sucrose; and grape juice reconstituted frozen
concentrate (8 fl. oz.) typically contains 11 gm of fructose. One
knowledgeable in the art would be able to select the appropriate type and
amount of fruit or fruit juice to serve as a source of fructose.
Any reference in this application to a quantity of fructose should be
understood as referring to the actual fructose content within the
carbohydrate source. For example, 100 gm of the honey in Table 1 would
provide 49 gm of fructose. One skilled in the art can readily calculate
how much of a carbohydrate source is required to deliver the desired
amount of fructose.
Fructose may be indirectly provided by feeding maltitol or sucrose to the
subject. Sucrose is hydrolyzed and absorbed in the small intestine as
glucose and fructose. Maltitol (glucose alpha-1,4 sorbitol) is hydrolyzed
and absorbed in the small intestine as glucose and sorbitol. Sorbitol is
dehydrogenated (via sorbitol dehydrogenase) in the liver to fructose.
Sorbitol alone is not a suitable indirect source of fructose, because it
is malabsorbed from the small intestine.
Commercial sources for fructose are readily available and known to one
practicing the art. For example, various high fructose corn syrups are
available from Cargil in Minneapolis, Minn. Liquid and powder fructose is
available from A. E. Staley in Decatur, Ill. Honey, fruit and fruit juices
are available from the local grocery stores.
Because the fructose is consumed prior to a meal, individual unit dose
size packages are preferred over bulk packaging. Suitable dosage forms
typically include tablet, caplet, lozenge, powder, crystal, fruit, syrup,
candy and liquid. Examples of preferred dosage forms typically include
crystalline fructose packaged in a sachet, fructose chewable tablets
packaged in a roll, individually wrapped hard candies, an 8 fl. oz bottle
of grape juice and one medium raw apple.
Typically, from about 1 to about 10 fructose doses are consumed prior to
the meal, preferably from about 1 to about 5, more preferably from about 1
to 2 fructose doses are consumed prior to the meal. One knowledgeable in
the art would be able to produce acceptable dosage forms by well known
manufacturing procedures in the food and confectionery industry.
As noted above, the fructose dose is consumed from about 10 to about 90
minutes before a meal, preferably from about 15 to about 75 minutes before
a meal, more preferably from about 30 to about 60 minutes before a meal.
A diabetic would typically practice the method of the invention 30 minutes
prior to a meal, by consuming 2 hard candies that contain 5 gm of fructose
each.
Numerous types of containers are readily available and know to one
practicing the art. Convenience is the primary criteria for selecting the
appropriate container depending on the dosage form. Examples of container
types typically include packets or sachets which are typically
manufactured of paper, foil and plastic film, and foil and plastic film
coated paper; blister packs which are typically manufactured of paper,
foil, plastic, plastic film; rolls or tubes which are typically
manufactured of paper, foil, plastic, plastic film; ampoules which may be
manufactured of plastic, reinforced paper and glass; and individual
wrappers which are typically manufactured of paper, foil, plastic film.
Claim 1 of 12 Claims
1. A method for blunting the postprandial
glycemic response to a meal, said method comprising feeding a diabetic
individual from about 2 grams to about 30 grams of a source of
supplemental fructose from about 10 minutes to about 90 minutes prior to a
meal, wherein the source of supplemental fructose is selected from the
group consisting of liquid fructose, powder fructose and crystalline
fructose, in a dosage form selected from the group consisting of sachet,
tablet, caplet, lozenge, powder, syrup, and liquid. ____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|